ANAVIP (Rare Disease Theraputics, Inc)
Welcome to the PulseAid listing for the ANAVIP drug offered from Rare Disease Theraputics, Inc. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Rare Disease Theraputics, Inc |
| NON-PROPRIETARY NAME: | Crotalidae Immune F(ab)2(Equine) |
| SUBSTANCE NAME: | PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE) |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-05-06 |
| END MARKETING DATE: | 0000-00-00 |
ANAVIP PLASMA DERIVATIVE Details:
| Item Description | ANAVIP from Rare Disease Theraputics, Inc |
| LABELER NAME: | Rare Disease Theraputics, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 24(mg/mL) |
| START MARKETING DATE: | 2015-05-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66621-0790_1b2f3aba-d32a-4112-9acd-46d969d47ff2 |
| PRODUCT NDC: | 66621-0790 |
| APPLICATION NUMBER: | BLA125488 |
Other PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE) Pharmaceutical Manufacturers / Labelers:
